Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
July 2017

Valbenazine (Ingrezza): The First Drug Approved to Treat TD
Valbenazine (Ingrezza), an inhibitor of vesicular monoamine transporter 2 (VMAT2), is the first medication approved by the FDA to treat tardive dyskinesia.

A Dietary Supplement to Reduce the Risk of Postpartum Depression?
In a small, open-label trial, a dietary supplement decreased the propensity for sadness in postpartum women.

Pimavanserin (Nuplazid) for Parkinson Disease Psychosis
Pimavanserin (Nuplazid), a new molecular entity, is the first drug approved by the FDA to treat Parkinson disease psychosis.

In Brief
Review Finds that Dietary Supplements and Special Diets Do Not Improve Autism Symptoms; Aerobic Exercise Improves Executive Function in Adults with Vascular Cognitive Impairment

Don't Forget Clozapine
A recent survey found that US residents are hesitant to prescribe clozapine (Clozaril and others) for patients with schizophrenia, citing fear of side effects and lack of sufficient training on how to properly prescribe and monitor clozapine treatment.

Continuing Medical Education credits available!

The CME posttest is now available!

Provided by The CME Institute of Physicians Postgraduate Press, Inc. After reading this volume of Biological Therapies in Psychiatry (BTP), the learner will be able to (1) discuss new psychiatric drugs, including side effects and drug interactions, and (2) describe new information on older medications and new biological treatments.

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To obtain credit, you must answer 17 of 24 questions correctly and return the answer sheet to the CME Institute of Physicians Postgraduate Press, Inc., by March 31, 2017. The cost for this activity is $30.

Options for completion:

  1. Download the 2016 CME Posttest. Mail or fax in the completed posttest by 3/31/17. Certificate will be emailed within 4-6 weeks.
  2. OR

  3. Go to www.cmeinstitute.com/BTP and complete the test online by 3/31/17. Certificate will be emailed immediately upon completion.